Early research (Phase 1)Active Not RecruitingNCT02650414What this trial is testingCD22 Redirected Autologous T Cells for ALLWho this might be right forB Cell LeukemiasB Cell Lymphomas University of Pennsylvania 41
Not applicableEnded earlyNCT00957736What this trial is testingChronic Graft-Versus-Host Disease in Patients Who Have Undergone Donor Stem Cell TransplantWho this might be right forCancer Vanderbilt-Ingram Cancer Center 252
Not applicableStudy completedNCT00701844What this trial is testingSharing Our Strength: A Research Study for Bone Marrow/Stem Cell Transplant SurvivorsWho this might be right forLeukemiaAcute LeukemiaAcute Lymphocytic Leukemia+3 more University of North Carolina, Chapel Hill 315
Not applicableLooking for participantsNCT06947044What this trial is testingBiomarkers in Patients With Anemia-Induced Thrombocytopenic BleedingWho this might be right forAcute LeukemiaAcute Myeloid Leukemia (AML)Acute Lymphocytic Leukaemia Donald Arnold 60
Post-approval studies (Phase 4)Study completedNCT00526409What this trial is testingLAL-AR-N-2005:Study Treatment for Children High Risk Acute Lymphoblastic LeukemiaWho this might be right forAcute Lymphoblastic Leukemia PETHEMA Foundation 40
Post-approval studies (Phase 4)Study completedNCT00576472What this trial is testingLearning Impairments Among Survivors of Childhood CancerWho this might be right forAcute Lymphoblastic LeukemiaBrain Tumors St. Jude Children's Research Hospital 469
Not applicableLooking for participantsNCT06845592What this trial is testingSafely Delivered Targeted High-dose Irradiation Followed by Adoptive Immunotherapy with Regulatory and Conventional T Cells to Increase Potency of Hematopoietic Stem Cell Transplantation in High-risk Acute LeukemiaWho this might be right forAcute Myeloid Leukaemia (AML)Acute Lymphoblastic Leukemia ALLHigh Risk Leukaemia+1 more University Of Perugia 51
Early research (Phase 1)Active Not RecruitingNCT00710892What this trial is testingCASPALLO: Allodepleted T Cells Transduced With Inducible Caspase 9 Suicide GeneWho this might be right forAcute Lymphoblastic LeukemiaNon-Hodgkin's LymphomaMyelodysplastic Syndrome+1 more Baylor College of Medicine 10
Testing effectiveness (Phase 2)Looking for participantsNCT06742515What this trial is testingBlinatumomab Plus Reduced-dose Chemotherapy in Treating B-ALLWho this might be right forPrecursor B-Cell Acute Lymphoblastic Leukemia First Affiliated Hospital of Zhejiang University 20
Not applicableStudy completedNCT06195735What this trial is testingForecasting Hypersensitivity Against PEG-asparaginase to Optimize Outcome in ALLWho this might be right forAcute Lymphoblastic Leukemia Aarhus University Hospital 649
Not applicableUnknownNCT03000335What this trial is testingEvaluation of ProALL miRs in Blood Specimen for Prediction of ALL Relapse RiskWho this might be right forB-cell Acute Lymphoblastic Leukemia Curewize Health Ltd. 65
Not applicableStudy completedNCT02708108What this trial is testingImproving Diet and Exercise in Acute Lymphoblastic Leukemia (IDEAL Weight in ALL)Who this might be right forB Precursor Type Acute Leukemia Children's Hospital Los Angeles 40
Testing effectiveness (Phase 2)Study completedNCT01297543What this trial is testingSafety Study of Human Myeloid Progenitor Cells (CLT-008) After Chemotherapy for LeukemiaWho this might be right forAcute Myeloid LeukemiaAcute Lymphoblastic LeukemiaChronic Myeloid Leukemia+1 more Cellerant Therapeutics 45
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07175415What this trial is testingHEM-iSMART E: Capivasertib + Venetoclax + Dexamethasone in Pediatric Patients With Relapsed or Refractory Hematological MalignanciesWho this might be right forAcute Lymphoblastic LeukemiaLymphoblastic Lymphoma (Precursor B-Lymphoblastic Lymphoma/Leukaemia) RecurrentLymphoblastic Lymphoma (Precursor B-Lymphoblastic Lymphoma/Leukaemia) Refractory+2 more Princess Maxima Center for Pediatric Oncology
Early research (Phase 1)Study completedNCT00005785What this trial is testingStem Cell (Modified Bone Marrow) Transplantation in HIV-Infected Patients With Blood CancerWho this might be right forHematologic NeoplasmHIV Infection National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 30
Testing effectiveness (Phase 2)Active Not RecruitingNCT02981628What this trial is testingInotuzumab Ozogamicin in Treating Younger Patients With B-Lymphoblastic Lymphoma or Relapsed or Refractory CD22 Positive B Acute Lymphoblastic LeukemiaWho this might be right forRecurrent B Acute Lymphoblastic LeukemiaRecurrent B Lymphoblastic LymphomaRefractory B Acute Lymphoblastic Leukemia+1 more Children's Oncology Group 80
Testing effectiveness (Phase 2)Looking for participantsNCT01371630What this trial is testingInotuzumab Ozogamicin and Combination Chemotherapy in Treating Patients With Acute Lymphoblastic LeukemiaWho this might be right forB Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1B Acute Lymphoblastic Leukemia, Philadelphia Chromosome NegativeBurkitt-Like Lymphoma With 11q Aberration+6 more M.D. Anderson Cancer Center 276
Early research (Phase 1)Study completedNCT02141828What this trial is testingDose Escalation and Expanded Cohort Study of EPZ-5676 in the Treatment of Pediatric Patients With Relapsed/Refractory Leukemias Bearing a Rearrangement of the MLL GeneWho this might be right forLeukemiaAcute Myeloid LeukemiaAcute Lymphocytic Leukemia+1 more Epizyme, Inc. 18
Testing effectiveness (Phase 2)UnknownNCT03318419What this trial is testingCladribine in Combination With GAP in Patients With Refractory/Relapsed Acute Lymphoblastic LeukemiaWho this might be right forAcute Lymphoblastic Leukemia Sun Yat-sen University 50
Early research (Phase 1)WithdrawnNCT07498465What this trial is testingFind the Highest Dose of SNDX-5613 (Revumenib) as a Treatment Option After Hematopoietic Stem Cell Transplant in Children With Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, and Mixed Phenotype Acute LeukemiaWho this might be right forAcute Lymphoblastic LeukemiaAcute Myeloid LeukemiaChildhood Acute Lymphoblastic Leukemia+3 more Children's Oncology Group